Zolgensma, an FDA approved gene therapy, supplements the production of the SMN protein to improve motor neuron function in children with spinal muscular atrophy after just one dose.
Researchers pinpoint the brain regions and brainwave frequencies associated with sleep-enhanced learning of a sequential finger tapping task.
A new study uncovers molecular changes which may explain why motor neurons, rather than other neurons, are affected by the childhood illness, SMA.
Researchers have identified a compound that can stabilize a protein implicated in ALS and SMN.
Researchers implicate a variant in the UBQLN4 gene as a possible cause of ALS. The variant disrupts cellular processes that drive motor neuron development.
··6 min read
Researchers report people with higher empathy process music with greater involvement in the brain's reward system and areas of the brain associated with social information processing.
A new study reveals a link between brain activation, cardiorespiratory fitness and executive function in older adults.
A new study reports on how our brain decides if performing a certain task is worth the effort.
GABA plays a vital role in controlling the involuntary tics associated with Tourette Syndrome.
A study suggests that spinal muscular atrophy (SMA), a genetic neuromuscular disease in infants and children, results primarily from motor circuit dysfunction, not motor neuron or muscle cell dysfunction, as is commonly thought. In a second study, the researchers identified the molecular pathway in SMA that leads to problems with motor function.
Researchers report a synthetic molecule can reduce tau and even reverse some neurological damage in mouse models of Alzheimer's disease.
A new drug shows promise for improving outcomes for people with SMA.
